Skip to main content
. 2020 Dec 8;21(24):9338. doi: 10.3390/ijms21249338
α alpha
α7nAchR α-7 Nicotinic acetylcholine receptor
α-syn alpha-Synuclein
AD Alzheimer’s disease
AHRs Aryl hydrocarbon receptors
ALS Amyotrophic lateral sclerosis
AMPA α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ATP Adenosine triphosphate
BBB Blood-brain barrier
CA Cinnabarinic acid
CNS Central nervous system
CSF Cerebrospinal fluid
DA Dopamine
DOPAC 3,4-Dihydroxyphenylacetic acid
EAE Experimental autoimmune encephalitis
FTD Frontotemporal dementia
GI Gastrointestinal
GPR35 G-protein receptor 35
HD Huntington’s disease
IDO-1 Indolamine 2,3-dioxygenase 1
IFNs Interferons
KATs Kynurenine aminotransferases
KMO Kynurenine 3-monooxygenase
KP Kynurenine pathway
KYN Kynurenine
KYNA Kynurenic acid
LBs Lewy bodies
l-KYN N-formyl-l-kynurenine
MPP(+) 1-Methyl-4-phenylpyridinium
MPTP 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
MS Multiple sclerosis
NAD+ Nicotinamide adenine dinucleotide
NMDA N-methyl-d-aspartate
PD Parkinson’s disease
PIC Picolinic acid
PPMS Primary progressive MS
QUIN Quinolinic acid
ROS Reactive oxygen species
RRMS Relapsing-remitting MS
SNP Single nucleotide polymorphism
SNpc Pars compacta of the substance nigra
TDO Tryptophan 2,3-dioxygenase
TDP-43 TAR DNA-binding protein 43
TRP Tryptophan
XA Xanthurenic acid